This study is a randomized, double-blind, parallel-controlled, multicenter clinical study to
evaluate the efficacy and safety of Xinnaoning capsule in the treatment of chronic stable
angina pectoris (Qi stagnation and blood stasis syndrome).
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER)